Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture
02 Novembre 2020 - 09:00AM
Business Wire
Joint venture demonstrates innovative strength
of two companies with impressive and trusted healthcare heritage in
the German wholesale market
Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation
(NYSE: MCK) today announced the completion of their previously
announced agreement to create a joint venture combining their
respective pharmaceutical wholesale businesses in Germany, Alliance
Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA
holds a 70 percent controlling equity interest in the joint venture
and McKesson holds the remaining 30 percent interest.
“At Walgreens Boots Alliance, we all look forward to working
together with McKesson Corporation on this joint venture,” said
Ornella Barra, co-chief operating officer, Walgreens Boots
Alliance. “It is a very exciting step for our Pharmaceutical
Wholesale Division and a unique chance for us to further develop
innovative services to manufacturers and pharmacists in
Germany.”
“The completion of this strategic partnership with Walgreens
Boots Alliance enables us to strengthen and secure the future of
pharmaceutical distribution in the German market,” said Kevin
Kettler, chairman of the management board and president McKesson
International. “Together, we look forward to delivering a
successful model of operations to benefit the German healthcare
ecosystem of patients, pharmacies and manufacturers.”
With future challenges in the healthcare sector, the new company
is committed to strengthening the pharmacist's position as a
healthcare professional, creating innovative added value services
and significantly enhancing digitalization and operational
excellence.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in
retail and wholesale pharmacy, touching millions of lives every day
through dispensing and distributing medicines, and through its
convenient retail locations, digital platforms and health and
beauty products. The company has more than 100 years of trusted
healthcare heritage and innovation in community pharmacy and
pharmaceutical wholesaling.
Including equity method investments, WBA has a presence in more
than 25 countries, employs more than 450,000 people and has more
than 21,000 stores.
WBA’s purpose is to help people across the world lead healthier
and happier lives. The company is proud of its contributions to
healthy communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA is a Participant of the United Nations
Global Compact and adheres to its principles-based approach to
responsible business.
WBA is included in FORTUNE’s 2020 list of the World’s Most
Admired Companies*, ranked first in the food and drugstore
category. This is the 27th consecutive year that WBA or its
predecessor company, Walgreen Co., has been named to the list.
More company information is available at
https://www.walgreensbootsalliance.com/
*© 2020, Fortune Media IP Limited. Used under license.
About McKesson
McKesson Corporation is a global leader in healthcare supply
chain management solutions, retail pharmacy, community oncology and
specialty care, and healthcare information solutions. McKesson
partners with pharmaceutical manufacturers, providers, pharmacies,
governments and other organizations in healthcare to help provide
the right medicines, medical products and healthcare services to
the right patients at the right time, safely and cost-effectively.
United by our ICARE shared principles, our employees work every day
to innovate and deliver opportunities that make our customers and
partners more successful — all for the better health of patients.
McKesson has been named a “Most Admired Company” in the healthcare
wholesaler category by FORTUNE, a “Best Place to Work” by the Human
Rights Campaign Foundation, and a top military-friendly company by
Military Friendly. For more information,
visit www.mckesson.com.
(WBA-GEN)
Cautionary Note Regarding Forward-Looking Statements: All
statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties,
including, but not limited to, those related to the ability to
realize the anticipated benefits of the joint venture and achieve
financial and operating results from the joint venture in the
amounts and at the times anticipated, as well as those described in
Item 1A (Risk Factors) of Walgreens Boots Alliance’s Form 10-K for
the fiscal year ended August 31, 2020, McKesson’s Form 10-K for the
fiscal year ended March 31, 2020, and in other documents that
Walgreens Boots Alliance or McKesson files or furnishes with the
Securities and Exchange Commission. Should one or more of these
risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially.
These forward-looking statements speak only as of the date they are
made. Each of Walgreens Boots Alliance and McKesson does not
undertake, and expressly disclaims, any duty or obligation to
update publicly any forward-looking statement after the date of
this release, whether as a result of new information, future
events, changes in assumptions or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201102005260/en/
Walgreens Boots Alliance Contacts: Walgreens Boots
Alliance Media Relations Contact International +44 (0)20 7980
8585
Investor Relations Contact Gerald Gradwell and Jay Spitzer +1
847 315 2922
McKesson Contacts: Media: David Matthews +1 214.952.0833
David.Matthews@McKesson.com
Investors: Holly Weiss +1 972.969.9174
Holly.Weiss@McKesson.com
Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024